Thinking of joining a study?

Register your interest

NCT05693857 | Recruiting | Patient-Perceived Versus


Perceive and Calculated CV Risk
Sponsor:

Chinese University of Hong Kong

Information provided by (Responsible Party):

Professor Bryan Ping Yen YAN

Brief Summary:

Cardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk to guide treatment decisions and engage patients in shared decision-making. Research has focused on refining the accuracy of these CV risk calculators for different populations, relatively little has been done to understand how patients perceive their own ASCVD risk. Accurate perception of a patient's risk by both the patient and the doctors is important because this is an important determinant of health-related behaviour. Patients often show optimistic bias when considering their own CV risk and consistently underestimate it. We aim to determine patient perceived versus actual risk of ASCVD in a Chinese population. We aim to better understand the degree to which patients underestimate or overestimate their ASCVD risk and whether patients are better or worse at estimating their ASCVD risk relative to their peers of the same age and sex. Finally, we aim to evaluate patients willingness to follow guideline recommended CV prevention and specifically lipid-lowering therapy.

Condition or disease

Patient-Perceived Versus

Intervention/treatment

Cardiovascular prevention guidelines

Detailed Description:

Cardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk to guide treatment decisions and engage patients in shared decision-making. Research has focused on refining the accuracy of these CV risk calculators for different populations, relatively little has been done to understand how patients perceive their own ASCVD risk. Accurate perception of a patient's risk by both the patient and the doctors is important because this is an important determinant of health-related behaviour. Patients often show optimistic bias when considering their own CV risk and consistently underestimate it. We aim to determine patient perceived versus actual risk of ASCVD in a Chinese population. We aim to better understand the degree to which patients underestimate or overestimate their ASCVD risk and whether patients are better or worse at estimating their ASCVD risk relative to their peers of the same age and sex. Finally, we aim to evaluate patients willingness to follow guideline recommended CV prevention and specifically lipid-lowering therapy.

Study Type : Observational
Estimated Enrollment : 1500 participants
Official Title: Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Willingness to Follow Recommendations for Cardiovascular Prevention
Actual Study Start Date : June 11, 2023
Estimated Primary Completion Date : February 11, 2028
Estimated Study Completion Date : August 11, 2028

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 40 Years to 90 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Aged 40 years and above
  • Consent to complete questionnaire
  • Lipid profile within 12 months
Exclusion Criteria
  • Known ASCVD defined as history of coronary heart disease (i.e. obstructive coronary disease, prior myocardial infarction, or prior coronary revascularization); cerebrovascular disease (i.e. stroke or transient ischemic attack); and peripheral arterial disease (i.e. obstructive peripheral disease, prior vascular amputation or prior revascularization)
  • Other chronic illness with life-expectancy <12 months

Perceive and Calculated CV Risk

Location Details


Please Choose a site



Perceive and Calculated CV Risk

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

Hong Kong,

The Chinese University of Hong Kong

Shatin, Hong Kong, 999077

Loading...